Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04368234 · ClinicalTrials.gov registry record
Duke COVID-19 Shared Data and Specimen Repository
A clinical trial of COVID-19, sponsored by Duke University.
- Active
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT04368234 is a study of COVID-19 that is active but no longer recruiting, run by Duke University. The registered enrollment target is 100,000 participants, above the 54,722-participant average among 203 other COVID-19 trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04368234, a study of COVID-19, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2020-04-18 |
| Est. Completion | 2028-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04368234
The ClinicalTrials.gov registry entry for NCT04368234 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54,722-participant average among 203 other COVID-19 trials with a reported enrollment target (83% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04368234 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04368234 about?
NCT04368234 is a clinical study titled "Duke COVID-19 Shared Data and Specimen Repository". The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.
What is the current status of trial NCT04368234?
This trial is currently active not recruiting. The enrollment target is 100,000 participants. The study started on 2020-04-18. Estimated completion is 2028-04-30.
What conditions does trial NCT04368234 study?
This clinical trial studies the following conditions: COVID-19.
Who is sponsoring clinical trial NCT04368234?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04368234 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.